![Image of Family who received injections](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/call_to_action_992x558/public/Stock%20Photo%20Crop-02.png?itok=-FRcBVo6)
Don't delay, get your COVID-19 vaccine or booster today!
Getting vaccinated or receiving a booster if you’re already vaccinated is the best thing you can do to help protect yourself, family and friends.
Vaccines.govFDA 2021 Year in Review - Working for You
Featured Topics
![New Era Feature](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/NewEra_Feature_1600x900.png?itok=Phrj00cf)
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
![Science-related icons juxtoposed on a background of prescription paperwork](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/Drug_Pricing.jpg?itok=J8A4aGeQ)
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
![Closeup shot of a nurse holding a patient's hand in comfort in a hospital](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/nurse-holding-patients-hand-1001423826.jpg?itok=YK0c-Jyy)
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Mar 22
Farm Fresh Produce LLC Recalls “TWA Agriculture Mixed Mushrooms” Because of Possible Health Risk
Food & Beverages
Mar 22
Pfizer Voluntary Nationwide Recall of Lots of ACCURETICTM (Quinapril HCl/Hydrochlorothiazide), Quinapril and Hydrochlorothiazide Tablets, and Quinapril HCl/Hydrochlorothiazide Tablets Due to N-Nitroso-Quinapril Content
Drugs
Mar 22
Consumer Alert: Undeclared Sulfites in "Licorice Flavor Olive"
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Image of lab technician placing samples onto tray.](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/Drug%20Approvals%20for%20Rare%20Diseases_1600%20x%20900_FINAL.png?itok=9ThuiBC5)
CDER Continues to Make Rare Diseases a Priority with Drug Approvals and Programming to Speed Therapeutic Development
Over the past decade or so, we have seen an upward trajectory in the percentage of drugs approved to treat rare or “orphan” diseases.
![Image with a green background promoting "FDA's Rare Disease Day 2022" on March 4th.](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/RD2022-March-Promo-Graphic-1600x900-V2.png?itok=e0W3Oj-Y)
Sharing Experiences in Rare Diseases Together
This year, the U.S. Food and Drug Administration is part of the worldwide community observing Rare Disease Week—February 28th through March 4th.
![Image with an assortment of pills in the background, with a text overlay that reads "2021 Generic Drugs."](https://public4.pagefreezer.com:443/content/FDA/23-03-2022T15:36/https://www.fda.gov/files/styles/medium_3/public/OGD%20GENERIC%20DRUGS%20SM%20graphic_1600x900.png?itok=Ythl8hKD)
Innovation and Scientific Collaboration Moved the Generic Drug Program Forward In 2021
2021 was a productive year for the agency’s generic drug program.
Recently Published Guidances
Mar 22
An Acceptable Circular of Information for the Use of Human Blood and Blood Components
Biologics
Mar 22
Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry
Biologics, Drugs, Medical Devices
Mar 15
Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
Biologics